Figure 2. Cytolytic activity of T cells measured by adenylate kinase (AK) release assay. AK release was quantifi ed by luminescence and expressed as RLU. A significant difference between patients with recurrence of malignancy and patients with disease-free survival is shown after 12 months (P < 0.05) only. Shown are mean ± SD. RFA: radiofrequency ablation; RLU: relative luminescence units
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.
